Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
for
Crohn Disease
Location: Charlestown MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06252493
Recruiting
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Boston MA, Hartford CT, Charlottesville VA, Houston TX,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase 1, Phase 2, Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, Hackensack NJ, New York NY, Baltimore MD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05372354
Phase 1, Phase 2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Providence RI, Boston MA, Stony Brook NY, Roslyn NY,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
for
Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer,
Location: Boston MA, New York NY
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT01439698
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Boston MA, New York NY, Winston-Salem NC, Charlotte NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase 1, Phase 2, Recruiting
Stereotactic Magnetic Resonance Guided Radiation Therapy